Kyle P. Murray

977 total citations
11 papers, 749 citations indexed

About

Kyle P. Murray is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Kyle P. Murray has authored 11 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Pharmacology and 5 papers in Clinical Biochemistry. Recurrent topics in Kyle P. Murray's work include Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Kyle P. Murray is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Kyle P. Murray collaborates with scholars based in United States. Kyle P. Murray's co-authors include Michael J. Rybak, Ryan P. Mynatt, Jason M. Pogue, Evan J Zasowski, Natalie A. Finch, Keith S. Kaye, Jing Zhao, Raymond Yost, Susan L. Davis and Jing Zhao and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Academic Emergency Medicine.

In The Last Decade

Kyle P. Murray

11 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle P. Murray United States 10 520 458 278 184 130 11 749
Emi Minejima United States 13 478 0.9× 324 0.7× 334 1.2× 245 1.3× 53 0.4× 26 766
Ryan P. Mynatt United States 17 730 1.4× 633 1.4× 483 1.7× 299 1.6× 136 1.0× 37 1.1k
Denis Bugnon France 16 290 0.6× 395 0.9× 179 0.6× 351 1.9× 54 0.4× 32 816
Chad A. Knoderer United States 14 147 0.3× 299 0.7× 45 0.2× 193 1.0× 84 0.6× 46 660
Lina Meng United States 13 178 0.3× 204 0.4× 133 0.5× 145 0.8× 24 0.2× 24 490
Melanie Smith United States 10 201 0.4× 177 0.4× 62 0.2× 199 1.1× 141 1.1× 33 543
Rachel M. Kenney United States 15 220 0.4× 153 0.3× 172 0.6× 230 1.3× 26 0.2× 74 805
Elodie von Dach Switzerland 15 166 0.3× 365 0.8× 164 0.6× 423 2.3× 57 0.4× 35 1.0k
Pieter De Cock Belgium 16 133 0.3× 449 1.0× 66 0.2× 263 1.4× 79 0.6× 64 856
Yazdan Mirzanejad Canada 13 183 0.4× 174 0.4× 126 0.5× 356 1.9× 25 0.2× 22 753

Countries citing papers authored by Kyle P. Murray

Since Specialization
Citations

This map shows the geographic impact of Kyle P. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle P. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle P. Murray more than expected).

Fields of papers citing papers by Kyle P. Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle P. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle P. Murray. The network helps show where Kyle P. Murray may publish in the future.

Co-authorship network of co-authors of Kyle P. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle P. Murray. A scholar is included among the top collaborators of Kyle P. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle P. Murray. Kyle P. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Jorgensen, Sarah C J, Kyle P. Murray, Abdalhamid M Lagnf, et al.. (2020). A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections. Infectious Diseases and Therapy. 9(1). 89–106. 29 indexed citations
2.
Alosaimy, Sara, Kyle P. Murray, Evan J Zasowski, et al.. (2020). Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistantStaphylococcus aureusComplicated Skin and Soft Tissue Infections. Clinical Infectious Diseases. 73(11). e4560–e4567. 7 indexed citations
3.
Murray, Kyle P., et al.. (2017). Ultrasound Assessment of the Transverse Abdominis During Functional Movement. Journal of Ultrasound in Medicine. 37(5). 1225–1231. 23 indexed citations
4.
Zasowski, Evan J, Kyle P. Murray, Trang D Trinh, et al.. (2017). Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin. Antimicrobial Agents and Chemotherapy. 62(1). 113 indexed citations
5.
Finch, Natalie A., Evan J Zasowski, Kyle P. Murray, et al.. (2017). A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity. Antimicrobial Agents and Chemotherapy. 61(12). 181 indexed citations
6.
Navalkele, Bhagyashri, Jason M. Pogue, Madiha Salim, et al.. (2016). Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime. Clinical Infectious Diseases. 64(2). 116–123. 137 indexed citations
7.
Kaye, Keith S., Bhagyashri Navalkele, Madiha Salim, et al.. (2016). Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship. Antimicrobial Agents and Chemotherapy. 60(6). 3743–3750. 50 indexed citations
8.
Mynatt, Ryan P., et al.. (2015). Nephrotoxicity Comparison of Two Commercially Available Generic Vancomycin Products. Antimicrobial Agents and Chemotherapy. 59(9). 5470–5474. 15 indexed citations
9.
Sethuraman, Usha, Nirupama Kannikeswaran, Kyle P. Murray, Marwan Zidan, & James M. Chamberlain. (2015). Prescription Errors Before and After Introduction of Electronic Medication Alert System in a Pediatric Emergency Department. Academic Emergency Medicine. 22(6). 714–719. 52 indexed citations
10.
Murray, Kyle P., Jing Zhao, Susan L. Davis, et al.. (2013). Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study. Clinical Infectious Diseases. 56(11). 1562–1569. 128 indexed citations
11.
Murray, Kyle P., et al.. (2013). Standard Versus Prolonged Doripenem Infusion for Treatment of Gram-Negative Infections. Annals of Pharmacotherapy. 47(7-8). 999–1006. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026